Critisense

Company Overview

Snapshot

Founded in January 2004, Critisense operates with 1–10 employees. The company is currently in a Pre-Funding stage.

Business overview

Critisense develops technology for real-time monitoring of patients' metabolic state, serving the healthcare industry. Its core product, CritiView, is a patient-monitoring system that provides continuous information via four physiological parameters, sensed at the tissue level, reflecting systemic metabolic state. CritiView monitors mitochondrial function and microcirculatory blood flow and oxygen saturation, offering early identification and warning of critical metabolic imbalances or tissue viability issues. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices, Diagnostics Devices, and Medical Monitors, targeting healthcare providers.

Company Intelligence Q&A

What is Critisense's primary focus?

Critisense focuses on developing technology for real-time monitoring of patients' metabolic state and tissue viability, particularly as an endpoint of resuscitation.

What is CritiView and what does it do?

CritiView is Critisense's patient-monitoring system that provides real-time, continuous information through four physiological parameters, sensed at the tissue level, to reflect the systemic metabolic state. It monitors mitochondrial function and microcirculatory blood flow and oxygen saturation.

What problem does CritiView address in critical care?

CritiView provides early identification and warning of critical metabolic imbalances or tissue viability issues, and serves as an endpoint of resuscitation. It detects physiological changes at the tissue level in advance of current critical-care monitors, enabling clinicians to take more refined corrective medical actions.

In which sector does Critisense primarily operate?

Critisense operates within the Health Tech & Life Sciences sector, with a specific focus on Medical Devices, Diagnostics Devices, and Medical Monitors.

What is the current status of Critisense?

Critisense is currently in a Non Active status as of November 2016, and is categorized as being in a Pre-Funding stage.